Loading clinical trials...
Loading clinical trials...
The objective of this study was to evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses for treating axillary hyperhidrosis in a large series of patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Grupo de Cirurgia Vascular
NCT02295891 · Axillary Hyperhidrosis
NCT04159610 · Primary Axillary Hyperhidrosis
NCT03836287 · Axillary Hyperhidrosis
NCT05546710 · Hyperhidrosis, Axillary Hyperhidrosis
NCT03658616 · Primary Axillary Hyperhidrosis
Hospital das Clinicas da FMUSP
São Paulo, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions